Overview Request Sample Pages Request Customization Download PDF
You are viewing: Canada Companion Animal Diagnostic Market analysis

The Canada Companion Animal Diagnostic Market was valued at $130.6 Million in 2026 and projected to reach to $180.7 Million by 2031, representing a compound annual growth rate of CAGR 6.7%. Canada's companion animal diagnostic market is positioned for sustained growth through 2031, driven by strong pet ownership demographics and increasing consumer investment in animal healthcare.

Canada Companion Animal Diagnostic Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Canada Companion Animal Diagnostic Market Trends and Insights

  • This steady expansion reflects Canada's strong pet ownership rates and increasing investment in veterinary healthcare infrastructure across the country.
  • Canada's market growth is driven by rising consumer spending on pet wellness, adoption of advanced diagnostic technologies in veterinary clinics, and heightened awareness of preventive care among Canadian pet owners. The Canadian companion animal diagnostic sector benefits from a well-established veterinary profession and regulatory framework that supports innovation in diagnostic testing.
  • Canada's market demonstrates consistent demand for imaging, laboratory, and point-of-care diagnostic solutions tailored to companion animals.
  • Between 2026 and 2031, Canada is expected to see increased adoption of digital diagnostics and remote monitoring tools, positioning the country as a key market within North America's broader companion animal healthcare ecosystem..

Key Market Statistics

  • CAGR (2026-2031) CAGR 6.7%
  • Market Size, 2026 ~USD 130.6 Million
  • Forecast, 2031 ~USD 180.7 Million
  • Country Canada

Canada Companion Animal Diagnostic Market Overview

Market Size & Growth :

Canada's companion animal diagnostic market is valued at $130.6 million in 2026 and is projected to reach $180.7 million by 2031, with a CAGR of 6.7%, outpacing many developed markets in steady expansion.

High Pet Ownership Rates :

Canada has one of the highest pet ownership rates globally, with approximately 58% of households owning pets, driving consistent demand for veterinary diagnostic services and preventive care solutions.

Veterinary Infrastructure Investment :

Significant investment in veterinary healthcare infrastructure across major Canadian cities and rural regions is expanding access to advanced diagnostic technologies and specialized veterinary services.

Consumer Spending Trends :

Canadian pet owners demonstrate increasing willingness to invest in premium veterinary care, with rising disposable incomes and pet humanization trends supporting growth in diagnostic service utilization.

Canada Companion Animal Diagnostic Market Dynamics

  • The market benefits from a well-developed veterinary infrastructure, particularly in urban centers like Toronto, Vancouver, and Montreal, where advanced diagnostic capabilities are becoming standard.
  • Rising awareness of preventive care and early disease detection among Canadian pet owners is accelerating adoption of diagnostic technologies. The Canadian market is expected to see continued expansion as veterinary clinics modernize their diagnostic equipment and services.
  • Government support for animal health initiatives, combined with the country's high standard of living and pet-centric culture, creates favorable conditions for market growth.
  • Regional expansion into secondary and tertiary markets presents significant opportunities for diagnostic service providers seeking to capture underserved pet owner populations across Canada..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Canada's companion animal diagnostic market is valued at $130.6 million in 2026 and will reach $180.7 million by 2031, growing at 6.7% CAGR.
    • Canada's market is driven by high pet ownership rates, increased consumer spending on preventive veterinary care, and adoption of advanced diagnostic technologies.
    • Canada's regulatory environment and established veterinary infrastructure support innovation and market expansion in companion animal diagnostics.
    • Canada is positioned as a key North American market, with growing demand for digital diagnostics and point-of-care testing solutions through 2031.

    Companion Animal Diagnostic Market Report Scope

    Report Metric Details
    Base Year 2026
    Fastest Growing Segment MOLECULAR DIAGNOSTICS (Technology)
    Forecast Period 2026–2031
    Growth Rate CAGR of 8.7% from 2026 to 2031
    Largest Segment CONSUMABLES (Product)
    Market Size Base Year (Billions) ~USD 3.56 (2026)
    Revenue Forecast (Billions) ~USD 5.4 (2031)
    Segments Covered Product, Technology, Type, Application, Animal Type, End User

    Canada Companion Animal Diagnostic Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Product

    • Consumables
    • Instruments

    By Technology

    • Clinical Biochemistry
    • Hematology
    • Immunodiagnostics
    • Molecular Diagnostics
    • Other Technologies
    • Urinalysis

    By Type

    • Allergen-Specific Immunodiagnostic Tests
    • Blood Gas & Electrolyte Analysis
    • Blood Gas & Electrolyte Analyzers
    • Blood Gas & Electrolyte Reagents, Clips, And Cartridges
    • Blood Glucose Strips
    • Clinical Chemistry Analysis
    • Clinical Chemistry Analyzers
    • Clinical Chemistry Reagents, Clips, And Cartridges
    • Elisa Tests
    • Glucose Monitoring
    • Glucose Monitors
    • Hematology Analyzers
    • Hematology Cartridges
    • Immunoassay Analyzers
    • Lateral Flow Assays
    • Microarrays
    • Nucleic Acid Sequencing
    • Other Immunodiagnostics Products
    • Other Molecular Diagnostics Products
    • Pcr Tests
    • Radioimmunoassays
    • Rapid Tests
    • Strip Readers
    • Urinalysis Clips & Cartridges
    • Urine Analyzers
    • Urine Glucose Strips
    • Urine Test Strips

    By Application

    • Bacteriology
    • Clinical Pathology
    • Other Applications
    • Parasitology
    • Virology

    By Animal Type

    • Cats
    • Dogs
    • Horses
    • Other Companion Animals

    By End User

    • Home Care Settings
    • Veterinary Hospital & Clinics
    • Veterinary Reference Laboratories
    • Veterinary Research Institutes & Universities

    CANADA: COMPANION ANIMAL DIAGNOSTICS MARKET, BY END USER, 2024–2031

    Segment20242025202620272028202920302031CAGR (%)
    HOME CARE SETTINGS66.57.27.98.79.510.511.610.2
    VETERINARY HOSPITAL & CLINICS106111.5118.8126.7135.2144.5154.6165.76.9
    VETERINARY REFERENCE LABORATORIES44.747.551.15559.36469.174.87.9
    VETERINARY RESEARCH INSTITUTES & UNIVERSITIES11.812.31313.714.415.316.117.15.7
    TOTAL168.5177.8190203.2217.6233.3250.4269.27.2

    Target Audience

    • Veterinary Diagnostic Companies : Manufacturers and suppliers of diagnostic equipment and services need Canada-specific market data to assess market potential, identify growth opportunities, and develop localized product strategies for Canadian veterinary clinics.
    • Veterinary Clinic Operators : Independent and chain veterinary practices require market insights to benchmark their diagnostic service offerings, understand competitive positioning, and make informed investment decisions in diagnostic technology upgrades.
    • Private Equity & Investors : Investment firms evaluating opportunities in Canada's pet healthcare sector need detailed market analysis to assess valuations, growth potential, and exit opportunities in the companion animal diagnostic space.
    • Market Entry & Expansion Strategists : Companies planning to enter or expand within the Canadian market require country-specific data on market size, growth rates, competitive landscape, and regional variations to inform go-to-market strategies.
    • Healthcare & Pet Industry Consultants : Consulting firms advising clients on veterinary healthcare investments need comprehensive Canada market data to support strategic recommendations, feasibility studies, and business case development.

    Key Companies in the Canada Companion Animal Diagnostic Market

    CompanyHQOwnershipStrongest segments
    MINDRAY MEDICAL INTERNATIONAL LIMITEDChinaPrivate CompanyPatient Monitoring and Life Support Products,In-Vitro Diagnostic Products,Medical Imaging Systems,
    QIAGEN NVNetherlandsPublic CompanySample technology consumables and instruments,Immune response and infectious disease diagnostics (incl. TB IGRA, transplant, viral load),Oncology, sexual and reproductive health assays,
    IDEXX LABORATORIES, INC.United StatesPublic CompanyCompanion Animal Group – in-clinic analyzers and SNAP rapid assays,Companion Animal Group – reference laboratories and telemedicine/consulting,Veterinary software, services, VetConnect PLUS and VetLab Station,
    FUJIFILM CORPORATIONJapanPublic CompanyHealthcare (medical devices, CDMO, pharma, regenerative medicine, cosmetics/supplements),Business Innovation (office equipment, document solutions, graphic communications, inkjet),Electronics (display, semiconductor materials, storage, industrial equipment, fine chemicals),
    THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
    BIOMéRIEUXFrancePublic CompanyClinical microbiology (culture media, VITEK 2, VITEK MS, AST including ETEST/VITEK REVEAL),Syndromic and molecular diagnostics (BIOFIRE, BIOFIRE SPOTFIRE, ARGENE, EMAG/NUCLISENS),Immunoassays and CLIA (VIDAS, Hybiome),
    BIONOTESouth KoreaPublic CompanyVeterinary fluorescence immunoassay and molecular diagnostics,Veterinary clinical biochemistry systems and reagents,Veterinary rapid immunoassay and ELISA kits,
    VIRBACFrancePublic CompanyCompanion-animal parasiticides and anti-infectives,Companion-animal specialty therapeutics & behavior (CKD diets, pheromones, mobility),Farm-animal vaccines (swine focus: Suigen range),

    MINDRAY MEDICAL INTERNATIONAL LIMITED

    Mindray Medical International Limited is a Chinese medical device manufacturer founded in 1991 with 8,400 employees. Operating as a private company, it specializes in diagnostic and monitoring equipment for healthcare applications.

    QIAGEN NV

    QIAGEN NV is a Dutch public company founded in 1984 with 5,500 employees. It provides molecular diagnostics, sample preparation, and life sciences research tools globally.

    IDEXX LABORATORIES, INC.

    IDEXX Laboratories, Inc. is a United States-based public company founded in 1983 with 11,000 employees. The company develops and manufactures diagnostic equipment and software for veterinary and water testing markets.

    FUJIFILM CORPORATION

    Fujifilm Corporation is a Japanese public company founded in 1934 with 73,526 employees. It operates across imaging, diagnostics, pharmaceuticals, and industrial products globally.

    THERMO FISHER SCIENTIFIC INC.

    Thermo Fisher Scientific Inc. is a United States public company founded in 1956 with 125,000 employees. It is a leading provider of laboratory equipment, reagents, and analytical instruments worldwide.

    BIOMéRIEUX

    bioMérieux is a French public company founded in 1963 with 14,894 employees. It specializes in in vitro diagnostics and microbiology testing solutions for clinical and industrial applications.

    BIONOTE

    BioNote is a South Korean public company founded in 2003 with 298 employees. The company develops and manufactures diagnostic devices and reagents for veterinary and clinical use.

    VIRBAC

    Virbac is a French public company founded in 1968 with 6,442 employees. It specializes in veterinary pharmaceuticals and animal health products.

    Reasons to Buy this Report

    • Market-Specific Sizing & Forecasts : Access precise market valuations for Canada ($130.6M in 2026, $180.7M in 2031) with country-specific CAGR of 6.7%, enabling accurate financial planning and investment decisions tailored to the Canadian market.
    • Competitive Landscape Intelligence : Understand the competitive dynamics specific to Canada's veterinary diagnostic sector, including key players, market share distribution, and regional competitive advantages across provinces.
    • Growth Driver Analysis : Identify Canada-specific growth catalysts including pet ownership trends, consumer spending patterns, veterinary infrastructure development, and regulatory environment shaping market expansion.
    • Regional Expansion Strategy : Develop targeted market entry and expansion strategies for Canadian regions, with insights into urban versus rural market opportunities and provincial variations in veterinary service adoption.
    • Investment & Partnership Opportunities : Identify high-potential investment targets, acquisition candidates, and partnership opportunities within Canada's companion animal diagnostic sector for strategic growth and market consolidation.

    Frequently asked questions

    What is the current size of Canada's companion animal diagnostic market?

    Canada's companion animal diagnostic market is valued at $130.6 million in 2026 and is expected to grow to $180.7 million by 2031.

    What is the growth rate of Canada's companion animal diagnostic market?

    Canada's companion animal diagnostic market is growing at a compound annual growth rate (CAGR) of 6.7% from 2026 to 2031.

    What factors are driving growth in Canada's companion animal diagnostic market?

    Growth in Canada's market is driven by high pet ownership rates, increased consumer spending on preventive veterinary care, adoption of advanced diagnostic technologies, and heightened awareness of pet wellness among Canadian pet owners.

    What diagnostic solutions are in demand in Canada's companion animal market?

    Canada's market shows strong demand for imaging diagnostics, laboratory testing, point-of-care diagnostic solutions, digital diagnostics, and remote monitoring tools for companion animals.

    How does Canada's companion animal diagnostic market compare to North America?

    Canada represents a significant segment of the North American companion animal diagnostic market, with a well-established veterinary infrastructure and regulatory framework that supports continued innovation and market growth through 2031.

    RESEARCH METHODOLOGY

    This research study extensively utilized both primary and secondary sources. It involved analyzing various factors influencing the industry to identify segmentation types, industry trends, key players, the competitive landscape, key market dynamics, and strategies employed by key players.

    Secondary Research

    This research study utilized a variety of comprehensive secondary sources, including directories, databases such as Bloomberg Business, Factiva, and Dun & Bradstreet, white papers, annual reports, company house documents, investor presentations, and SEC filings from various companies. Secondary research was employed to gather information crucial for an in-depth, technical, market-oriented, and commercial analysis of the companion animal diagnostics market. This approach also helped identify key players in the industry and allowed for classification and segmentation based on emerging trends at the most detailed level. Furthermore, significant developments pertaining to both market and technological perspectives were documented. A database of primary industry leaders was created as part of this secondary research.

    Primary Research

    In the primary research process, we interviewed a range of sources from both the supply and demand sides to gather qualitative and quantitative information for this report. Primary sources from the supply side include project/sales/marketing/business development managers, presidents, CEOs, vice presidents, chairpersons, chief operating officers, chief strategy officers, directors, chief information officers, and chief medical information officers related to the companion animal diagnostics market. Primary sources from the demand side include R&D product development teams in animal health companies, veterinary clinicians, diagnostic laboratory managers, and procurement heads at veterinary reference laboratories.

    Companion Animal Diagnostic Market Size, and Share

    Note: C-level executives include CEOs, COOs, CTOs, and VPs. Other designations include sales, marketing, and product managers.
    Tiers are defined based on a company’s total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The total size of the companion animal diagnostics market was determined through data triangulation across three approaches, as described below. After each approach, the weighted average of the three was calculated based on the level of assumptions used in each.

    Companion Animal Diagnostic Market Top Down and Bottom Up Approach

    Data Triangulation

    After arriving at the market size, the total market was divided into several segments and subsegments. Data triangulation and market breakdown procedures were employed as applicable to complete the overall market engineering process and obtain exact statistics for all segments and subsegments.

    Market Definition

    Companion animal diagnostics use plasma, serum, blood, urine, feces, and tissue samples to detect, monitor, and manage diseases and health conditions in dogs, cats, horses, and other household pets. The companion animal diagnostics market includes diagnostic instruments, test kits, reagents, and consumables used in veterinary clinics and laboratories, covering technologies such as clinical chemistry analyzers, hematology analyzers, immunodiagnostics and ELISA test kits, urinalysis systems, molecular diagnostic assays, glucose monitoring systems, and blood gas–electrolyte analyzers. These products support routine wellness screening, disease diagnosis, treatment monitoring, and preventive healthcare in companion animals.

    Key Stakeholders

    • Companion animal diagnostic manufacturers
    • Companion animal diagnostic distributors and suppliers
    • Companion animal R&D companies
    • Veterinary reference laboratories
    • Veterinary hospitals and clinics
    • Veterinary universities and research institutes
    • Government associations
    • Market research and consulting firms
    • Venture capitalists and investors
    • Distributors, channel partners, and third-party suppliers

    Report Objectives

    • To define, describe, segment, and forecast the companion animal diagnostics market by product, technology, application, animal type, end user, and region
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall companion animal diagnostics market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the companion animal diagnostics market in five main regions (along with their respective key countries): North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile the key players in the companion animal diagnostics market and comprehensively analyze their core competencies and market shares
    • To analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, and partnerships

    Available customizations:

    Based on the given market data, MarketsandMarkets offers customization to meet your company’s specific needs. The following customization options are available for the report:

    Company Information
    • Detailed analysis and profiling of additional market players (up to 5)
    Geographic Analysis
    • Further breakdown of the Rest of European companion animal diagnostics market into Austria, Finland, Switzerland, and other countries
    • Further breakdown of the Rest of Latin American companion animal diagnostics market into Colombia, Chile, and other countries
    Competitive Landscape Assessment
    • Market share analysis for North America and Europe, which provides market shares of the top 3–5 key players in the companion animal diagnostics market
    • Competitive leadership mapping for established players in the US

     

    Get the Full Companion Animal Diagnostic Market Report

    Full forecast, segment splits, and company analysis for all Companion Animal Diagnostic Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status